PE-Labeled HLA-A*1101 KRAS Complex Protein, Human (VVGAGGVGK, HEK293)

HLA-A*1101 is an important member of the MHC class I family and plays an important role in antigen presentation and immune surveillance. This complex is linked to the HLA-A*1101 allele and actively presents antigenic peptides to cytotoxic T lymphocytes, significantly promoting immune responses. PE-Labeled HLA-A*1101 KRAS Complex Protein, Human (VVGAGGVGK, HEK293) is a recombinant protein dimer complex containing HLA-A*1101 and B2M/Beta-2-microglobulin Protein, expressed by HEK293 , with labeled tag and VVGAGGVGK peptide. PE-Labeled HLA-A*1101 KRAS Complex Protein, Human (VVGAGGVGK, HEK293), has molecular weight of 55-60 kDa & 14 kDa, respectively.

The HLA-A*1101 is an integral member of the MHC class I family, playing a critical role in antigen presentation and immune surveillance. Characterized by its association with the HLA-A*1101 allele, this complex protein actively participates in presenting antigenic peptides to cytotoxic T lymphocytes, contributing significantly to the orchestration of immune responses. The PE labeling adds specificity to its antigen-binding capabilities, potentially influencing immune reactions in the context of cancers expressing KRAS antigens. As part of the MHC class I family, the HLA-A*1101 underscores its significance in advancing our understanding of immune processes and holds promise for applications in research focused on antigen presentation and immune system dynamics in the context of KRAS-associated malignancies.

Human

HEK293

Q5S3G3 (G25-T305)&P61769 (I21-M119)&VVGAGGVGK

3105&567

55-60 kDa&14 kDa

Greater than 90% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.